BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23085755)

  • 1. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.
    Huang WH; Chang MC; Tsai KS; Hung MC; Chen HL; Hung SC
    Oncogene; 2013 Sep; 32(37):4343-54. PubMed ID: 23085755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells promote formation of colorectal tumors in mice.
    Tsai KS; Yang SH; Lei YP; Tsai CC; Chen HW; Hsu CY; Chen LL; Wang HW; Miller SA; Chiou SH; Hung MC; Hung SC
    Gastroenterology; 2011 Sep; 141(3):1046-56. PubMed ID: 21699785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
    De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
    J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
    Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC
    Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model.
    Nakagaki S; Arimura Y; Nagaishi K; Isshiki H; Nasuno M; Watanabe S; Idogawa M; Yamashita K; Naishiro Y; Adachi Y; Suzuki H; Fujimiya M; Imai K; Shinomura Y
    J Gastroenterol; 2015 Sep; 50(9):962-74. PubMed ID: 25680886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of in vivo models investigating angiogenesis in breast cancer.
    Gehmert S; Gehmert S; Bai X; Klein S; Ortmann O; Prantl L
    Clin Hemorheol Microcirc; 2011; 49(1-4):519-26. PubMed ID: 22214723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
    Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
    Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model.
    Yang L; Zhang Y; Cheng L; Yue D; Ma J; Zhao D; Hou X; Xiang R; Cheng P
    Hum Gene Ther; 2016 Mar; 27(3):267-77. PubMed ID: 26756933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
    De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
    J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
    Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
    J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
    Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT
    Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
    Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
    Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.